CATUG provides novel CRO/CDMO services with a particular focus on mRNA vaccines and therapeutics, as well as gene and cell therapy (GCT). Plasmid, mRNA, LNP, and analytical QC are our four-pillar technology platforms. CATUG strong expertise and know-how aims to provide end-to-end solutions to its clients in the whole life cycle of mRNA therapeutics and GCT product development. CATUG customizes unique services and creative solutions to fit each client’s needs and timeline.
CATUG
